← Insider buys
MRNA

Moderna, Inc. · Healthcare

Director Noubar Afeyan sold $1.3M of Moderna, Inc.

Sold$1,296,800
$129.68Price
10,000Shares

What MRNA did after the filing

Filed Sep 9Copier in Sep 12
The stock from Mon, Sep 12 open, $142.00
−6.3%
S&P 500, same days
−6.9%

Measured over 30 trading days, to the Oct 24 close.

Traded Wed, Sep 7. Filed Fri, Sep 9, 7:30 PM ET, after the close. Returns use the Sep 12 open and the Oct 24 close. Not investment advice.